13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001913464
Total reported value
$118.0M
$118.0M
209 檔
13.3%
The Q4 2024 SEC filing reveals that AlphaCentric Advisors LLC held a total portfolio value of $118.0M, covering 209 public equity positions.
In Q4 2024, AlphaCentric Advisors LLC adopted a defensive or profit-taking posture, trimming 3 positions and completely liquidating 29 holdings to manage risk exposure.
Showing top 200 holdings (of 209 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 4.73% | +0.01% | — | |
| 2 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 3.60% | — | — | |
| 3 | JNJ | Johnson & Johnson | Stock-Healthcare | 2.62% | -0.02% | — | |
| 4 | SHY | Ishares 1-3 Year Treasury Bo | ETF-Gov Bonds | 2.39% | +0.12% | +550.87% | |
| 5 | ABBV | Abbvie Inc | Stock-Healthcare | 2.31% | — | — | |
| 6 | MRK | Merck & Co. Inc. | Stock-Healthcare | 2.24% | — | -5.85% | |
| 7 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 2.17% | — | — | |
| 8 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.07% | — | — | |
| 9 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 2.00% | — | — | |
| 10 | GMED | Globus Medical Inc - A | Stock-Healthcare | 2.00% | +0.02% | — | |
| 11 | RPV | Invesco S&p 500 Pure Value E | ETF-Large Cap & Growth | 1.99% | -1.39% | — | |
| 12 | IWD | Ishares Russell 1000 Value E | ETF-Other | 1.98% | -1.33% | — | |
| 13 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.93% | -0.22% | +196.48% | |
| 14 | LAMR | Lamar Advertising Co-a | Stock-Real Estate | 1.82% | — | — | |
| 15 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.66% | — | — | |
| 16 | PINE | Alpine Income Property Trust | Stock-Other | 1.54% | — | — | |
| 17 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 1.53% | — | — | |
| 18 | REET | Ishares Global Reit ETF | ETF-Other | 1.44% | — | — | |
| 19 | STXS | Stereotaxis Inc | Stock-Other | 1.37% | -0.23% | — | |
| 20 | IEI | Ishares 3-7 Year Treasury Bo | ETF-Gov Bonds | 1.34% | -0.25% | +272.23% | |
| 21 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.25% | -0.09% | — | |
| 22 | FLNG | FLEX LNG Ltd. | Stock-Other | 1.20% | — | — | |
| 23 | BFS | Saul Centers Inc | Stock-Other | 1.16% | -0.03% | — | |
| 24 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 1.11% | — | — | |
| 25 | SOUN | Soundhound Ai Inc-a | Stock-Tech | 1.09% | +0.04% | -56.00% | |
| 26 | GPK | Graphic Packaging Holding Co | Stock-Consumer Disc | 1.08% | -0.15% | — | |
| 27 | ABT | Abbott Laboratories | Stock-Healthcare | 1.05% | -0.03% | — | |
| 28 | PFE | Pfizer Inc | Stock-Healthcare | 1.03% | — | +10.88% | |
| 29 | ELV | Elevance Health Inc | Stock-Healthcare | 0.99% | — | — | |
| 30 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.97% | -0.63% | +201.77% | |
| 31 | DHR | Danaher CORP | Stock-Healthcare | 0.96% | — | — | |
| 32 | GNW | Genworth Financial Inc | Stock-Financials | 0.93% | — | — | |
| 33 | BDX | Becton Dickinson And Co | Stock-Healthcare | 0.89% | — | — | |
| 34 | ATRC | Atricure Inc | Stock-Other | 0.79% | — | — | |
| 35 | CTO | Cto Realty Growth Inc | Stock-Other | 0.79% | -0.29% | — | |
| 36 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 0.75% | — | -67.58% | |
| 37 | AXR | Amrep CORP | Stock-Other | 0.72% | -0.63% | — | |
| 38 | ROK | Rockwell Automation Inc | Stock-Industrials | 0.71% | +0.12% | +11.11% | |
| 39 | CIM | Chimera Investment CORP | Stock-Other | 0.70% | — | +256.58% | |
| 40 | ARAY | Accuray Inc | Stock-Other | 0.69% | — | — | |
| 41 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.69% | — | — | |
| 42 | EXK | Exact Sciences CORP | Stock-Materials | 0.66% | — | -60.70% | |
| 43 | PRCT | Procept Biorobotics CORP | Stock-Other | 0.64% | -0.08% | — | |
| 44 | RKLB | Rocket Lab Corporation | Stock-Industrials | 0.64% | — | +66.67% | |
| 45 | EHC | Encompass Health CORP | Stock-Healthcare | 0.63% | — | — | |
| 46 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 0.62% | — | — | |
| 47 | SYK | Stryker CORP | Stock-Healthcare | 0.62% | — | — | |
| 48 | NVDA | Nvidia CORP | Stock-Tech | 0.58% | — | -27.52% | |
| 49 | SMRT | Smartrent Inc | Stock-Other | 0.57% | — | — | |
| 50 | HO1 | Hologic Inc | Stock-Other | 0.55% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | +4.7% | NEW | New buy |
| 2 | UNH | Unitedhealth Group Inc | +3.6% | NEW | New buy |
| 3 | JNJ | Johnson & Johnson | +2.6% | NEW | New buy |
| 4 | ABBV | Abbvie Inc | +2.3% | NEW | New buy |
| 5 | TMO | Thermo Fisher Scientific Inc | +2.2% | NEW | New buy |
| 6 | SHY | Ishares 1-3 Year Treasury Bo | +2.1% | +550.87% | Add |
| 7 | AZNN | Astrazeneca Plc-spons Adr | +2.1% | NEW | New buy |
| 8 | NVO | Novo-nordisk A/s-spons Adr | +2% | NEW | New buy |
| 9 | GMED | Globus Medical Inc - A | +2% | NEW | New buy |
| 10 | RPV | Invesco S&p 500 Pure Value E | +2% | NEW | New buy |
| 11 | IWD | Ishares Russell 1000 Value E | +2% | NEW | New buy |
| 12 | LAMR | Lamar Advertising Co-a | +1.8% | NEW | New buy |
| 13 | BSX | Boston Scientific CORP | +1.7% | NEW | New buy |
| 14 | PINE | Alpine Income Property Trust | +1.5% | NEW | New buy |
| 15 | NVS | Novartis Ag-sponsored Adr | +1.5% | NEW | New buy |
| 16 | ISRG | Intuitive Surgical Inc | +1.5% | +196.48% | Add |
| 17 | REET | Ishares Global Reit ETF | +1.4% | NEW | New buy |
| 18 | VRTX | Vertex Pharmaceuticals Inc | +1.3% | NEW | New buy |
| 19 | EXK | Exact Sciences CORP | -0.9% | -60.70% | Trim |
| 20 | ADAM | Adamas Trust Inc | -1% | EXIT | Sold out |
| 21 | RVNCEUR | Revance Therapeutics Inc | -1% | EXIT | Sold out |
| 22 | APLSUSD | Apellis Pharmaceuticals Inc | -1% | EXIT | Sold out |
| 23 | GSK | Gsk Plc-spon Adr | -1.1% | EXIT | Sold out |
| 24 | AMPH | Amphastar Pharmaceuticals In | -1.1% | EXIT | Sold out |
| 25 | ELS | Equity Lifestyle Properties | -1.1% | EXIT | Sold out |
| 26 | ITCIEUR | Intra-cellular Therapies Inc | -1.1% | EXIT | Sold out |
| 27 | ACT | Enact Holdings Inc | -1.1% | EXIT | Sold out |
| 28 | MITT | Tpg Mortgage Investment Trus | -1.2% | EXIT | Sold out |
| 29 | JAZZ | Jazz Pharmaceuticals plc | -1.3% | EXIT | Sold out |
| 30 | MIRM | Mirum Pharmaceuticals Inc | -1.3% | EXIT | Sold out |
| 31 | SRPT | Sarepta Therapeutics Inc | -1.4% | -87.72% | Trim |
| 32 | RPRX | Royalty Pharma plc | -1.4% | EXIT | Sold out |
| 33 | NBIX | Neurocrine Biosciences Inc | -1.4% | -83.63% | Trim |
| 34 | QQQ | Invesco Qqq Trust Series 1 | -1.5% | EXIT | Sold out |
| 35 | QQQM | Invesco Nasdaq 100 ETF | -1.5% | EXIT | Sold out |
| 36 | ATEC | Alphatec Holdings Inc | -1.5% | EXIT | Sold out |
| 37 | MFA | Mfa Financial Inc | -1.6% | EXIT | Sold out |
| 38 | AM6 | Amicus Therapeutics Inc | -1.6% | EXIT | Sold out |
| 39 | UTHR | United Therapeutics CORP | -1.7% | EXIT | Sold out |
| 40 | RWT | Redwood Trust Inc | -1.7% | EXIT | Sold out |
| 41 | DVAX | Dynavax Technologies CORP | -1.7% | EXIT | Sold out |
| 42 | BMRN | Biomarin Pharmaceutical Inc | -1.7% | EXIT | Sold out |
| 43 | DX | Dynex Capital Inc | -1.7% | EXIT | Sold out |
| 44 | INDV | Indivior Pharmaceuticals, Inc. | -1.8% | EXIT | Sold out |
| 45 | ARGX | Argenx Se - Adr | -1.8% | EXIT | Sold out |
| 46 | MTG | Mgic Investment CORP | -1.9% | EXIT | Sold out |
| 47 | EFC | Ellington Financial Inc | -1.9% | EXIT | Sold out |
| 48 | LKFT | Lakefront Biotherapeutic-adr | -2.3% | EXIT | Sold out |
| 49 | HRMY | Harmony Biosciences Holdings | -2.9% | EXIT | Sold out |
| 50 | RITM | Rithm Capital CORP | -3.2% | EXIT | Sold out |
According to official SEC Form 13F filings, AlphaCentric Advisors LLC reported a total U.S. public equity portfolio value of $118.0M across 209 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LLY, UNH, JNJ) accounted for 13.3% of total reported equity market value during Q4 2024.
Top New Position Initiated
LLY
市值: $4.7M
Top Position Liquidated / Trimmed
RITM
前期市值: $4.3M
During Q4 2024, AlphaCentric Advisors LLC's top holdings by market value included LLY (4.7%)、UNH (3.6%)、JNJ (2.6%). The largest single position, LLY, represented 4.7% of total portfolio value.
In Q4 2024, AlphaCentric Advisors LLC made 50 total portfolio adjustments, initiating 16 new buys, adding to 2 positions, trimming 3 holdings, and fully liquidating 29 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.